China Stem Cells: Plan to issue H shares and list on The Stock Exchange of Hong Kong Limited.

Shenzhou Cell Announcement: The company held its sixth meeting of the third board of directors on April 2, 2026, and approved the proposals on "Issuance of H shares and listing on the Stock Exchange of Hong Kong" and "Plan for issuance of H shares and listing on the Stock Exchange of Hong Kong." The company plans to issue overseas listed shares and apply for listing on the main board of the Stock Exchange of Hong Kong to enhance the company's capital strength and overall competitiveness, and further promote its internationalization strategy. The issuance and listing are still subject to approval by the company's shareholders' meeting, as well as the China Securities Regulatory Commission, the Securities and Futures Commission of Hong Kong, and the Stock Exchange of Hong Kong, and other relevant government departments, regulatory agencies, and securities exchanges.